Clinical Trials for Recurrent B Acute Lymphoblastic Leukemia

Find clinical trials for recurrent b acute lymphoblastic leukemia. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

NCT ID: NCT02981628

This clinical trial is investigating a treatment called inotuzumab ozogamicin for younger patients, aged 1 to 21, who have certain types of blood cancers, including B-lymphoblastic lymphoma and B a...

Recruiting

Phase: PHASE2 Type: interventional Locations: New Haven, Connecticut, United States, Brooklyn, New York, United States +166 more

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

NCT ID: NCT05418088

This clinical trial is studying a new treatment for certain types of blood cancers, specifically targeting those that have come back or have not responded to previous treatments. The treatment invo...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Columbus, Ohio, United States

ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

NCT ID: NCT03698552

This clinical trial is studying a new treatment called ADCT-602 for patients with a type of blood cancer known as B-cell acute lymphoblastic leukemia (B-ALL) that has either come back after treatme...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Monrovia, California, United States

CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia

NCT ID: NCT06777979

This clinical trial is studying a new treatment called CD19-CD22-Bispecific CAR T Cell Therapy for children and young adults up to 21 years old who have certain types of leukemia, specifically Acut...

Recruiting

Phase: PHASE1 Type: interventional Locations: Memphis, Tennessee, United States

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

NCT ID: NCT04872790

This clinical trial is studying a combination of four medications—venetoclax, dasatinib, prednisone, rituximab, and blinatumomab—to see how well they work in treating patients with a specific type ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Portland, Oregon, United States

Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease

NCT ID: NCT03441061

This clinical trial is studying a treatment called inotuzumab ozogamicin for patients with a type of blood cancer known as B-cell acute lymphoblastic leukemia (ALL). Specifically, it focuses on pat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

NCT ID: NCT01371630

This clinical trial is investigating a new treatment approach for patients with acute lymphoblastic leukemia (ALL), a type of blood cancer. The study is looking at a combination of a targeted thera...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions